期刊文献+

前列腺癌中TSP-1表达与血管生成之间关系的探讨 被引量:3

Correlation between the Expression of Thrombospondin-1 and the Angiogenesis in Prostatic Carcinoma
下载PDF
导出
摘要 目的:探讨前列腺癌中肿瘤血管生成与凝血酶敏感蛋白-1(TSP-1)表达的相关性。方法:采用免疫组织化学法检测22例前列腺癌中微血管密度(MVD)值和TSP-1的表达。结果:前列腺癌中TSP-1阳性表达率为72.7%(16/22),绝大多数表达位于肿瘤细胞的胞浆中,少数表达位于肿瘤细胞外基质。在22例前列腺癌组织中平均MVD为71.21±31.14/100倍视野,具有TSP-1强表达的肿瘤组织中显示MVD值较高,TSP-1的免疫活性与微血管密度间呈显著相关性(r=0.54,P=0.009)。结论:TSP-1在前列腺癌组织中呈高表达与前列腺癌的血管生成相关,有促进前列腺癌中血管生长的作用,并参与前列腺癌血管基因的表达。 Objective: To observe the expression of thrombospondin-1 (TSP-1) separately in prostatic carcinoma, and its relationship with the angiogenesis. Methods: The expression of TSP-1 and the value of microvessel density (MVD) were studied in 22 prostatic carcinoma patients using immunohistochemistry. Results: Positive expression of TSP-1 protein detected inl6 of the 22 (72.7%) cases. Most positive staining for TSP-1 was seen in the cytoplasm of the cancer cells, some was in the extracellular matrix. The mean MVD in 22 cases with prostatic carcinoma was 71.21±31.14 vessels per 100 field of vision. Tumors with a high expression of TSP-1 showed a high value of MVD and the correlation between TSP-1 immunocompetence and microvessel density was highly significant (r=0.54, P=0.009). Conclusions: The TSP-1 is strongly expressed in most prostatic carcinoma and were associated with neovascularization-1 expression might TSP-1 is likely to contribute to the extensive neovascularization and increased TSP- participate in angiogenic phenotype in prostatic carcinoma.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2006年第3期138-140,144,共4页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金资助(编号:30471731)
关键词 凝血酶敏感蛋白-1 微血管密度 前列腺癌 Thrombospondin-1 Microvessal density Prostatic carcinoma
  • 相关文献

参考文献13

  • 1takahashi R, Tanaka S, Hiyama T, et al. Hypoxia-inducible factor-lalpha expression and angiogenesis in gastrointestinal stromal tumor of the stomach[J]. Oncol Rep, 2003, 10(4): 797-802.
  • 2Clczardin P, Frappart L, Clerget M, ct al. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal,hyperplastic, and neoplastic human breast [1]. Cancer Res, 1993,53(6): 1421-1430.
  • 3Tanaka K, Sonoo H, Kurebayashi J, et al. Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma[J]. Clin Cancer Res, 2002, 8(5): 1125-1131.
  • 4Benin N, Clezardin P, Kubiak R, et al. Thrombospondin-1 and-2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia [J]. Cancer Res, 1997,57(3): 396-399.
  • 5Kwak C, Jin C, Lee C, et al. Thrombospondin-1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia [J]. BJU Int, 2002, 89(3): 303-309.
  • 6Kasper HU, Ebert M, Malfertheiner P, et al. Expression of thrombospondin-1 in pancreatic carcinoma: correlation with microvessel density[l]. Virchows Arch, 2001, 438(2): 116-120.
  • 7Maeda K, Nishiguchi Y, Yashiro M, et al. Expression of vascular endothelial growth factor and thrombospondin-1 in colorectal carcinoma[J]. IntJ Mol Med, 2000, 5(4): 373-378.
  • 8Rice AJ, Steward MA, Quinn GM. Thrombospondin-1 protein expression relates to good prognostic indices in dutal carcinoma in situ of the breast[J].J Clin Pathol, 2002, 55(12): 921 -925.
  • 9Miyanaga K, Kato Y, Nakamura T, et al. Expression and role of thrombospondins -1 in colorectal cancer[J]. Anticancer Res, 2002,22(6C): 3941-3948.
  • 10ZhangJ, ho R, Oue N, et al. Expression of thrombospondins -1 is correlated with microvessel density in gastric carcinoma[J]. Virchows Arch, 2003, 442(6): 563-568.

同被引文献27

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1368
  • 2江军,金锡御,靳风烁,王洛夫.雄激素对大鼠前列腺不同分叶雄激素受体及其mRNA表达的影响[J].第三军医大学学报,2003,25(13):1153-1156. 被引量:1
  • 3邹戈,杨罗艳,刘紫庭,李杰贤.VEGF、TSP-1在膀胱移行细胞癌中的表达[J].中国临床医学,2006,13(2):275-277. 被引量:1
  • 4Kaygusuz G,Tulungy O,Baltaci S,et al.Micvovessel density and regulators of angiodenesis in malignant and nonmalignant prostate tissue [J]. Int Urol Nephrol, 2007,39( 3 ) : 841-850.
  • 5Sweat S D,Pacelli A,Bergstralh E J,et al. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer[J]. Urol, 1999,161 (4) : 1229-1232.
  • 6Culig Z,Hobisch A,Hittmair A,et al. Expression,structure and function of androgen receptor in advanced prostatic carcinoma[J]. Prostate, 1998,35( 1 ) :63-70.
  • 7Doll A,Reiher F K,Crawford S E,et al.Thrombospondin-1 vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in prostate[J]. The Prostate, 2001 , 49 ( 4 ) : 293-305.
  • 8Kwak C,Jin R J,Lee C,et al.Thrombospondin-1,vascularendothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia[J]. BJU Int, 2002,89(3 ) : 303-309.
  • 9Vallbo C,Wang W,Damber E,et al.The expression of thrombos pondin-1 in benign prostatic hyperplasia and prostatic intrae pithelial neop lasia is decreased in prostate cancer[J]. BJU Int,2004,93(9) : 1339-1343.
  • 10Taraboletti G,Morridelli L,Donnini S,et al.The heparin binding 25kDa fragment of thrombospondin-1 and modulates gelatinase and TI MP-2 production in endothelial cells[J]. The FASEB J, 2000, 14( 12 ): 1674-1676.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部